Journal Watch · Proceedings of the National Academy of Sciences (PNAS) · 2026
One mechanism, two diseases: Involvement of enzyme-substrate complexes in the pathogenesis of celiac disease and rheumatoid arthritis.
A shared pathomechanism raises the possibility that RA, like exogenous cereal gluten proteins drive immunopathology in CeD, is driven by T cell reactions to foreign antigen.
TL;DR
A shared pathomechanism raises the possibility that RA, like exogenous cereal gluten proteins drive immunopathology in CeD, is driven by T cell reactions to foreign antigen.
Key findings
- This pathomechanism places enzyme-reactive B cells in the center of events.
- This notion resonates well with B cell depleting therapies being successfully explored for RA.
- A shared pathomechanism raises the possibility that RA, like exogenous cereal gluten proteins drive immunopathology in CeD, is driven by T cell reactions to foreign antigen.
What they did
In CeD, recent insights obtained from studies of antigen-specific immune cells have established a mechanistic model that integrates these key features by a pivotal involvement of enzyme-substrate complexes. Conceivably, the pathomechanism of RA parallels that of CeD in which autoreactive B cells by internalizing enzyme-substrate complexes present posttranslationally modified peptides to CD4<sup>+</sup> T cells.
Full abstract (original)
Background: Celiac disease (CeD) and rheumatoid arthritis (RA) share several key features. In both diseases HLA class II allotypes are the major genetic determinants, in both diseases there are antibodies to posttranslationally modified peptides (i.e., deamidated peptides in CeD and citrullinated peptides in RA) and in both diseases there are autoantibodies to enzymes that mediate these peptide modifications (i.e., transglutaminase 2 for CeD and peptidyl arginine deiminase 2 and 4 for RA).
What they did: In CeD, recent insights obtained from studies of antigen-specific immune cells have established a mechanistic model that integrates these key features by a pivotal involvement of enzyme-substrate complexes. Conceivably, the pathomechanism of RA parallels that of CeD in which autoreactive B cells by internalizing enzyme-substrate complexes present posttranslationally modified peptides to CD4<sup>+</sup> T cells.
Results & conclusions: This pathomechanism places enzyme-reactive B cells in the center of events. This notion resonates well with B cell depleting therapies being successfully explored for RA. A shared pathomechanism raises the possibility that RA, like exogenous cereal gluten proteins drive immunopathology in CeD, is driven by T cell reactions to foreign antigen.
Abstract © the authors / Proceedings of the National Academy of Sciences (PNAS) (2026). Reproduced here for discussion and indexing, with attribution. Read the original at https://doi.org/10.1073/pnas.2600933123 · PubMed 42696555.
Why it matters for pharma & biotech
- Relevant to General & Medicine teams tracking Proceedings of the National Academy of Sciences (PNAS) for new targets, mechanisms and biomarkers.
- As earlier-stage work, its near-term value is target validation and assay design rather than clinical decisions.
- For searchers: the full abstract is reproduced below, so you can judge relevance before opening the publisher page.
Limitations & what to check in the full text
- This brief is based on the published abstract only. Effect sizes, subgroup results and safety detail in the full text may qualify the headline findings.
- The abstract reports its conclusions qualitatively, without headline effect sizes — read the full text before citing a magnitude.
Frequently asked questions
What did this Proceedings of the National Academy of Sciences (PNAS) study find?
A shared pathomechanism raises the possibility that RA, like exogenous cereal gluten proteins drive immunopathology in CeD, is driven by T cell reactions to foreign antigen.
What type of study is this?
It is a research study, published in Proceedings of the National Academy of Sciences (PNAS) in 2026. In CeD, recent insights obtained from studies of antigen-specific immune cells have established a mechanistic model that integrates these key features by a pivotal involvement of enzyme-substrate complexes.
Where can I read the original paper?
The original is at the publisher via DOI 10.1073/pnas.2600933123. PubMed ID: 42696555. BioStudioAI reproduces the abstract for discussion and links to the source.
This brief: BioStudioAI Journal Watch, 29 October 2026. https://biostudioai.com/blog/papers/one-mechanism-two-diseases-involvement-of-enzyme-substrate-complexes-in-933123/
Reading papers is step one. Analysing the data is the work.
BioStudioAI turns raw lab files into QC'd results, statistics, figures, reports and slides — hosted on your servers, every number computed, nothing typed.
Open BioStudioAI More guides